Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
What explains functioning from the perspective of people with multiple sclerosis?
Dealing with excess of zeros in the statistical analysis of magnetic resonance imaging lesion count in multiple sclerosis.
What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders?
IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity.
Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients.
Association of interleukin-1 gene polymorphisms with multiple sclerosis: a meta-analysis.
Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins.
Glial Cell Development and Function in Zebrafish.
Risk factors for multiple sclerosis: decreased vitamin D level and remote Epstein-Barr virus infection in the pre-clinical phase of multiple sclerosis.
Clinical characteristics of optic neuritis in koreans greater than 50 years of age.
Triptolide with Potential Medicinal Value for Diseases of the Central Nervous System.
B lymphocytes in neuromyelitis optica.
Dopaminergic dysfunction is associated with IL-1β-dependent mood alterations in experimental autoimmune encephalomyelitis.
A Pilot Study: examining the effects and tolerability of structured dance intervention for individuals with multiple sclerosis.
Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
[Translation and cross-cultural adaptation of the Multiple Sclerosis Walking Scale (MSWS-12) into Brazilian Portuguese].
Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.
Multiple Sclerosis: Risk Factors and Their Interactions.
Mesenchymal Stem Cell-Based Therapy in a Mouse Model of Experimental Autoimmune Encephalomyelitis (EAE).
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders.
Meningeal and Choroid Plexus Cells - Novel Drug Targets for CNS Disorders.
Longitudinal JCV serology in multiple sclerosis patients preceding natalizumab-associated progressive multifocal leukoencephalopathy.
The utility of cerebrospinal fluid analysis in patients with multiple sclerosis.
Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.
Distress associated with patients' symptoms and depression in a sample of Mexican caregivers of individuals with MS.
Pages
« first
‹ previous
…
240
241
242
243
244
245
246
247
248
…
next ›
last »